6th Annual WML Academic Symposium

Poster Presentation
Time: 4:00-5:30
Presenter(s): Christopher Demitraszek, Daniel McClure, and Mary-Russell Wagstaff
Title: Impact of the JUPI, ER trial on US statin prescribing after 2008 for primary prevention of cardiovascular disease (CVD) in adults 18 years or greater
Developed under the guidance of Dr. Melissa Holland , Clinical Research

The JUPITER clinical trial suggested prevailing clinical practices could expand to reduce heart disease risk in some patients. We analyzed US prescribing of the trial drug rosuvastatin, and the statin class, before and after JUPITER. An association exists between year and rosuvastatin prescriptions, but not between year and statin prescriptions.